News

Search for Articles
Jul 13, 2022
Renovacor Announces Data from Pilot Pig Study Showing Successful Cardiac Transduction with REN-001 Delivered Via Low-Dose Retrograde Coronary Sinus Infusion Published in Journal of the American College of Cardiology: Basic to Translational Research

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...

Read More
May 5, 2022
XII Medical Completes $30 Million Series A Financing

UNION CITY, Calif., May 5, 2022 /PRNewswire/ -- XII Medical, Inc., a private health technology company,...

Read More
Apr 26, 2022
AtaCor Medical to Present Preliminary Results from First-in-Human Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Study

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. (“AtaCor”) announced today that it will present initial findings...

Read More
Apr 25, 2022
NIDO Surgical Announces the Acquisition of SEPIA Device

BOSTON, April 25, 2022 /PRNewswire/ -- NIDO Surgical announced today the acquisition of its innovative epicardial...

Read More
Mar 28, 2022
Renovacor Announces the Appointment of Fred Driscoll as Chief Financial Officer

PHILADELPHIA--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to...

Read More
Mar 25, 2022
Renovacor Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

PHILADELPHIA--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...

Read More
78910111213